Population-based case-control study of alpha 1-antitrypsin and SLC11A1 in Crohn's disease and ulcerative colitis

Inflammatory Bowel Diseases

Volumn 14, Issue 8, 2008, Pages 1112-1117

  Kotlowski, Roman ^a   Bernstein, Charles N ^a   Silverberg, Mark S ^b   Krause, Denis O ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Alpha 1 antitrypsin activity; Inflammatory bowel disease; Secretory leucocyte peptidase inhibitor

Indexed keywords

ADENINE; ALPHA 1 ANTITRYPSIN; CYSTEINE; CYTOSINE; GUANINE; LEUKOCYTE ELASTASE INHIBITOR; METHIONINE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NUCLEOTIDE; SERINE; THREONINE; THYMINE;

3' UNTRANSLATED REGION; ARTICLE; BLOOD ANALYSIS; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; CROHN DISEASE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; ULCERATIVE COLITIS;

ADULT; ALPHA 1-ANTITRYPSIN; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS);

EID: 49749146389     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20425     Document Type: Article

References (27)

1. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39:596-604.
2. Searle S, Blackwell JM. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with an toimmune versus infectious disease susceptibility. J Med Genet. 1999; 36:295-299.
3. Thuraisingam T, Sam H, Moisan J, et al. Delayed cutaneous wound healing in mice lacking solute carrier Hal (formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor. J Invest Dermatol. 2006;126:890-901.
4. Peyrin-Biroulet L, Chamaillard M. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res. 2007; 13:135-139.
5. Folwaczny C, Urban S, Schröder M, et al. Alphal-antitrypsin alleles and phenotypes in patients with inflammatory bowel disease. Scand J Gastroenterol. 1998;33:78-81.
6. Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2007;56:669-675.
7. Piitulainen E, Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alphal-antitrypsin deficiency (PiZZ), Eur Respir J. 1999;13:247-251.
8. Elzouki AN, Eriksson S, Löfberg R, et al. The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis. Inflamm Bowel Dis. 1999;5:246-252.
9. Taddei C, Audrain MA, Reumaux D, et al. Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1999;11:1293-1298.
10. Chermesh I, Azriel A, Alter-Koltunoff M, et al. Crohn's disease and SLC11A1 promoter polymorphism. Dig Dis Sci. 2007;52:1632-1635.
11. Kojima Y, Kinouchi Y, Takahashi S, et al. Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene. Tissue Antigens. 2001;58:379-384.
12. Crawford NP, Eichenberger MR, Colliver DW, et al. Evaluation of SLC11A1 as an inflammatory bowel disease candidate gene. BMC Med Genet. 2005;6:10.
13. Sechi LA, Gazouli M, Sieswerda LE, et al. Relationship between Crohn's disease, infection with Mycobacterium avium subspecies para-tuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol. 2006;12:7161-164.
14. Zaahl MG, Winter TA, Warnich L, et al. The -237C→T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population. Int J Colorectal Dis. 2006;21:402-408.
15. Dry P. Rapid detection of alpha-1-antitrypsin deficiency by analysis of a PCR-induced TaqI restriction site. Hum Gen. 1991;87:742-744.
16. Brant SR, Wang MH, Rawsthorne P, et al. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2007;102:313-323.
17. Sakamoto Y, Akaike, H. Analysis of cross classified data by AIC. Ann Inst Statist Math. 1978;18:30-31.
18. Yang P, Tremaine WJ, Meyer RL, et al. Alpha1-antitrypsin deficiency and inflammatory bowel diseases. Mayo Clin Proc. 2000;75: 450-455.
19. Bergenfeldt M, Nyströrn M, Bohe M, et al. Localization of immunoreactive secretory leukocyte protease inhibitor (SLP1) in intestinal mucosa. J Gastroenterol. 1996;31:18-23.
20. Molmenti EP, Perlmutter DH, Rubin DC. Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest. 1993; 92:2022-2034.
21. Beatty K, Bieth SJ, Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem. 1980;255:3931-3934.
22. Liu J, Fujiwara TM, Buu NT, et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet. 1995;56: 845-853.
23. Takahashi K, Hasegawa Y, Abe T, et al. SLC11A1 (formerly NRAMP1) polymorphisms associated with multidrug-resistant tuberculosis. Tuberculosis (Edinb). 2008;88:52-57.
24. Taype CA, Castro JC, Accinelli RA, et al. Association between SLC11A1 polymorphisms and susceptibility to different clinical forms of tuberculosis in the Peruvian population. Infect Genet Evol. 2006;6:361-367.
25. Xu YZ, Di Marco S, Gallouzi I, et al. RNA-binding protein HuR is required for stabilization of SLC11A1 mRNA and SLC11A1 protein expression. Mol Cell Biol. 2005;18:8139-8149.
26. Bourhis LL, Werts C. Role of Nods in bacterial infection. Microbes Infect. 2007;9:629-636.
27. Fortier A, Min-Oo G, Forbes J, et al. Single gene effects in mouse models of host: pathogen interactions. J Leukoc Biol. 2005;77:868-877.